WW 277 (Lithium 450 mg)
Pill imprint WW 277 has been identified as Lithium carbonate extended release 450 mg.
Lithium is used in the treatment of bipolar disorder; borderline personality disorder; intermittent explosive disorder; depression; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WW 277
- Strength:
- 450 mg
- Color:
- Yellow
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- West-Ward Pharmaceutical Corporation
- National Drug Code (NDC):
- 00143-1277
- Inactive Ingredients:
- alginic acid
corn starch
magnesium stearate
povidone
ferric oxide yellow
More about lithium
Consumer resources
- Lithium
- Lithium controlled-release and extended-release tablets
- Lithium syrup
- Lithium (Advanced Reading)
- Other brands: Lithobid, Eskalith, Eskalith-CR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
